Co-localization of apolipoprotein E and β-amyloid in plaques and cerebral blood vessels of aged non-human primates

Alzheimer's Reports

Volumn 1, Issue 2, 1998, Pages 119-128

  Summers, James B ^a   Hill, William D ^a   Prendergast, Mark A ^a   Buccafusco, Jerry J ^a,b  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

amyloid; Alzheimer's disease; Apolipoprotein E; Astrocytes; Dual label immunohistochemistry; Glial fibrillary acidic protein; Non human primate

Indexed keywords

EID: 0000710496     PISSN: 14616130     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Bales KR, Verina T, Dodel RD et al. (1997). Lack of apolipoprotein E dramatically reduces amyloid β-peptide deposition. Nature Genet 17, 263-264.
2. Boyles JK, Zoellner CD, Anderson LJ et al. (1989). A role for apolipoprotein E, apolipoprotein A-1, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve. J Clin Invest 83, 1015-1031.
3. Brown MS, Herz J, Kowal RC et al. (1991) The LDL receptor-related protein (LRP): double agent or decoy? Curr Opin Lipidol 2, 65-72.
4. Chan W, Fornwald J, Brawner M et al. (1996). Native complex formation between apolipoprotein E isoforms and the Alzheimer's disease peptide Aβ. Biochemistry 35, 7123-7130.
5. Corder EH, Saunders AM, Strittmatter WJ et al. (1993). Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261, 921-923.
6. Das HK, McPherson J, Bruns GAP et al. (1985). Isolation, characterization, and mapping to chromosome 19 of the human apolipoprotein E gene. J Biol Chem 260, 6240-6247.
7. Evans KC, Berger EP, Cho CG et al. (1995). Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer disease. Proc Natl Acad Sci USA 92, 763-767.
8. Gearing M, Rebeck GW, Hyman BT et al. (1994). Neuropathology and apolipoprotein E profile of aged chimpanzees: implications for Alzheimer disease. Proc Natl Acad Sci USA 91, 9382-9386.
9. Gearing M, Mori H, Mirra SS (1996). Aβ-peptide length and apolipoprotein E genotype in Alzheimer's disease. Ann Neurol 39, 395-399.
10. Gearing M, Tigges J, Mori H et al. (1997). β-Amyloid deposition in brains of aged orangutans. Neurobiol Aging 18, 139-146.
11. Han SH, Einstein G, Weisgraber KH et al. (1994). Apolipoprotein E is localized to the cytoplasm of human cortical neurons: a light and electron microscopic study. J Neuropathol Exp Neurol 53, 535-544.
12. Hanlon CS and Rubinsztein DC (1995). Arginine residues at codons 112, 158 in the apolipoprotein E gene correspond to the ancestral state in humans. Atherosclerosis 112, 85-90.
13. Ignatius MJ, Shooter EM, Pitas RE et al. (1987). Lipoprotein uptake by neuronal growth cones in vitro. Science 236, 959-962.
14. Iwatsubo T, Odaka A, Suzuki N et al. (1994). Visualization of Aβ 42(43) and Aβ 40 in senile plaques with end-specific Aβ monoclonals: evidence that an initially deposited species is Aβ 42(43). Neuron 13, 45-53.
15. Kanemaru K, Iwatsubo T and Ihara Y (1996). Comparable amyloid β -protein (Aβ) 42(43) and Aβ40 deposition in the aged monkey brain. Neurosci Lett 214, 196-198.
16. Kida E, Golabek AA, Wisniewski T et al. (1994). Regional differences in apolipoprotein E immunoreactivity in diffuse plaques in Alzheimer's disease brain. Neurosci Lett 167, 73-76.
17. Mahley RW (1988). Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240, 622-630.
18. Metzger RE, LaDu MJ, Pan JB et al. (1996). Neurons of the human frontal cortex display apolipoprotein E immunoreactivity: implications for Alzheimer's disease. J Neuropathol Exp Neurol 55, 372-380.
19. Morelli L, Wei L, Amorim A et al. (1996). Cerebrovascular amyloidosis in squirrel monkeys and rhesus monkeys: apolipoprotein E genotype. FEBS Lett 379, 132-134.
20. Mufson EJ, Benzing WC, Cole GM et al. (1994). Apolipoprotein E-immunoreactivity in aged rhesus monkey cortex: colocalization with amyloid plaques. Neurobiol Aging 15, 621-627.
21. Nakai M, Kawamata T, Taniguchi T et al. (1996). Expression of apoE mRNA in ratmicroglia Neurose; Lett 211, 41-44.
22. Nakamura S, Kiatipattanasakul W, Nakayama H et al. (1996). Immunohistochemical characteristics of the constituents of senile plaques and amyloid angiopathy in aged cynomolgus monkeys. J Med Primatol 25, 294-300.
23. Namba Y, Tomonaga M, Kawasaki H et al. (1991). Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res 541, 163-166.
24. Pitas RE, Boyles JK, Lee SH et al. (1987). Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins. Biochim Biophys Acta 917, 148-161.
25. Poduri A, Gearing M, Rebeck GW et al. (1994). Apolipoprotein E4 and beta amyloid in senile plaques and cerebral blood vessels of aged rhesus monkeys. Am J Path 144, 1183-1187.
26. Poirier J, Hess M, May PC et al. (1991). Cloning of hippocampal poly(A) RNA sequences that increase after entorhinal cortex lesion in adult rat. Mol Brain Res 9, 191-195.
27. Rebeck GW, Reiter JS, Strickland DK et al. (1993). Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron 11, 575-580.
28. Schmechel DE, Saunders AM, Strittmatter WJ et al. (1993). Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci USA 90, 9649-9653.
29. Stoll G, Meuller HW, Trapp BD et al. (1989). Oligodendrocytes but not astrocytes express apolipoprotein E after injury of rat optic nerve. Glia 2, 170-176.
30. Strittmatter WJ and Roses AD (1995). Apolipoprotein E and Alzheimer disease. Proc Natl Acad Sci USA 92, 4725-4727.
31. Strittmatter WJ, Saunders AM, Schmechel D et al. (1993a). Apolipoprotein E: high-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 90, 1977-1981.
32. Strittmatter WJ, WeisgraberKH, Huang DY et al. (1993b). Binding of human apolipoprotein E to synthetic amyloid β peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc Natl Acad Sci USA 90, 8098-8102.
33. Summers JB, Prendergast MA, Hill WD et al. (1997). Localization of ubiquitin in the plaques of five aged primates by dual-label fluorescent immunohistochemistry. Alz Res 3, 11-21.
34. Tsai MS, Tangalos EG, Petersen RC et al. (1994). Apolipoprotein E: risk factor for Alzheimer disease. Am J Hum Genet 54, 643-649.
35. Uchihara T, Duyckaerts C, He Y et al. (1995). ApoE immunoreactivity and microglial cells in Alzheimer's disease brain. Neurosci Lett 195, 5-8.
36. Wisniewski T, Frangione B (1992). Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci Lett 135, 235-238.
37. Wisniewski T, Golabek A, Matsubara E et al. (1993). Apolipoprotein E: binding to soluble Alzheimer's β-amyloid. Biochem Biophys Res Comm 192, 359-365.
38. Yamada T, Kondo A, Takamatsu JI et al. (1995). Apolipoprotein E mRNA in the brains of patients with Alzheimer's disease. J Neurol Sci 129, 56-61.
39. Yamaguchi H, Ishiguro K, Sugihara S et al. (1994). Presence of apolipoprotein E on extracellular neurofibrillary tangles and on meningeal blood vessels precedes the Alzheimer β-amyloid deposition. Acta Neuropathol 88, 413-419